Abstract:Uterine leiomyoma or fibroids are the most common prevalent noncancerous tumors of the uterine muscle layer. Common symptoms associated with fibroids include pelvic pain, heavy menstrual bleeding, anemia, and pelvic pressure. These tumors are a leading cause of gynecological care but lack long-term therapy as the origin and development of fibroids are not well understood. Several next-generation sequencing technologies have been performed to identify the underlying genetic and epigenetic basis of fibroids. However, there remains a systemic gap in our understanding of molecular and biological process that define uterine fibroids. Recent epitranscriptomics studies have unraveled RNA modifications that are associated with all forms of RNA and are thought to influence both normal physiological functions and the progression of diseases. We quantified RNA expression profiles by analyzing publicly available RNA-seq data for 15 known epigenetic mediators to identify their expression profile in uterine fibroids compared to myometrium. To validate our findings, we performed RT-qPCR on a separate cohort of uterine fibroids targeting these modifiers confirming our RNA-seq data. We then examined protein profiles of key m6A modifiers in fibroids and their matched myometrium. In concordance with our RNA expression profiles, no significant differences were observed in these proteins in uterine fibroids compared to myometrium. To determine abundance of RNA modifications, mRNA and small RNA from fibroids and matched myometrium were analyzed by UHPLC MS/MS. In addition to the prevalent N6-methyladenosine (m6A), we identified 11 other known modifiers but did not identify any aberrant expression in fibroids. We then mined a previously published dataset and identified differential expression of m6A modifiers that were specific to fibroid genetic sub-type. Our analysis also identified m6A consensus motifs on genes previously identified to be dysregulated in uterine fibroids. Overall, using state-of-the-art mass spectrometry, RNA expression and protein profiles, we characterized and identified differentially expressed m6A modifiers in relation to driver mutations. Despite the use of several different approaches, we identified limited differential expression of RNA modifiers and associated modifications in uterine fibroids. However, considering the highly heterogenous genomic and cellular nature of fibroids, and the possible contribution of single molecule m6A modifications to fibroid pathology, there is a need for greater in-depth characterization of m6A marks and modifiers in a larger and varied patient cohort.

H19 lncRNA identified as a master regulator of genes that drive uterine leiomyomas

Integrated Analysis of Long Noncoding RNAs and Mrnas Reveals Their Potential Roles in the Pathogenesis of Uterine Leiomyomas

Integrating leiomyoma genetics, epigenomics, and single-cell transcriptomics reveals causal genetic variants, genes, and cell types

Characterization of m6A modifiers and RNA modifications in uterine fibroids

Unraveling the Molecular Landscape of Uterine Fibroids, Insights into and Stem Cell Involvement

Identification and Validation of miRNA-TF-mRNA Regulatory Networks in Uterine Fibroids

A systems-based approach to uterine fibroids identifies differential splicing associated with abnormal uterine bleeding

Molecular and Cellular Insights into the Development of Uterine Fibroids

Circular RNA expression profiling identifies novel biomarkers in uterine leiomyoma

Update on the Role and Regulatory Mechanism of Extracellular Matrix in the Pathogenesis of Uterine Fibroids

Estrogen Regulates MAPK-Related Genes through Genomic and Nongenomic Interactions between IGF-I Receptor Tyrosine Kinase and Estrogen Receptor-Alpha Signaling Pathways in Human Uterine Leiomyoma Cells

The Tumor Suppressive Effect of Long Non-Coding RNA FRMD6-AS2 in Uteri Corpus Endometrial Carcinoma

PLP1 may serve as a potential diagnostic biomarker of uterine fibroids

LncRNA H19 Suppresses Metastasis of Follicular Thyroid Carcinoma via the IGF1/JAK/STAT Pathway

Epigenetic Regulation in Uterine Fibroids-The Role of Ten-Eleven Translocation Enzymes and Their Potential Therapeutic Application

Uterine fibroids may play a protecting role against endometrial carcinoma in Chinese women with gynecological diseases

Fine Mapping of the Uterine Leiomyoma Locus on 1q43 Close to a Lncrna in the RGS7-FH Interval

Lipopolysaccharide Activated TLR4/NF-κB Signaling Pathway of Fibroblasts from Uterine Fibroids.

Highly expressed lncRNA H19 in endometriosis promotes aerobic glycolysis and Histone lactylation

Hsa_circ_0056686, derived from cancer-associated fibroblasts, promotes cell proliferation and suppresses apoptosis in uterine leiomyoma through inhibiting endoplasmic reticulum stress